Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Once approved, retatrutide will likely be prescribed to people with obesity who have not responded well to existing GLP 1 medications
Active ingredient: The main chemical in a medication
Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations
They were randomly assigned to receive either a placebo, varying doses of retatrutide, or 1.5 mg dulaglutide through weekly injections
US$ 21.83
US$ 26.16
US$ 21.94
US$ 27.43
US$ 26.94
US$ 27.13
